These data showed that the increase of PD-1 expression and the decrease of glycolysis induced by blocking the lactate/GPR81 pathway could enhance the combinational anti-tumor effects of metformin and the PD-1/PD-L1 blockade. The gene discussed is HCAR1; the disease is neoplasm.